A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death

Journal of Experimental Medicine

Volumn 189, Issue 6, 1999, Pages 999-1004

  Ouaaz, Fateh ^b   Li, Ming ^b   Beg, Amer A ^a  

^a 1110 Fairchild Center ^*  (United States)

^b NONE

Author keywords

Apoptosis; Fas; Gene expression; Immune regulation; Nuclear Factor B

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD40 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; FIBROBLAST; GENE ACTIVATION; GENE CONTROL; GENE TARGETING; IMMUNE RESPONSE; IMMUNOGENETICS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; INTERFERON TYPE II; LIGASES; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033560024     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.6.999     Document Type: Article

References (38)

1. Medzhitov, R., and C.A. Janeway, Jr. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9.
2. Medzhitov, R., and C.A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-298.
3. Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
4. Whitham, S., S.P. Dinesh-Kumar, D. Choi, R. Hehl, C. Corr, and B. Baker. 1994. The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor. Cell. 78:1101-1115.
5. Ip, V.T., M. Reach, Y. Engstrom, L. Kadalayil, H. Cai, S. Gonzalez-Crespo, K. Tatei, and M. Levine. 1993. Dif, a dorsal-related gene that mediates an immune response in Drosophila. Cell 75:753-764.
6. Ip, Y.T., and M. Levine. 1994. Molecular genetics of Drosophila immunity. Curr. Opin. Genet. Dev. 4:672-677.
7. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
8. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
9. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature. 376:167-170.
10. Doi, T.S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953-961.
11. Caamano, J.H., C.A. Rizzo, S.K. Durham, D.S. Barton, C. Raventos-Suarez, C.M. Snapper, and R. Bravo. 1998. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185-196.
12. Franzoso, G., L. Carlson, L. Poljak, E.W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, et al. 1998. Mice deficient in nuclear factor (NF)-κB/ p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147-159.
13. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
14. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
15. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274: 782-784.
16. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell. 80:529-532.
17. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell. 83:1091-1100.
18. Kundig, T.M., M.F. Bachmann, C. DiPaolo, J.J. Simard, M. Battegay, H. Lother, A. Gessner, K. Kuhlcke, P.S. Ohashi, H. Hengartner, et al. 1995. Fibroblasts as efficient antigenpresenting cells in lymphoid organs. Science. 268:1343-1347.
19. Ting, J.P., and A.S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8-16.
20. Baldwin, A.S., Jr., and P.A. Sharp. 1988. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA. 85:723-727.
21. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M.B. Urban, P. Kourilsky, P.A. Baeuerle, and A. Israël. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1007-1018.
22. Baldwin, A.S., Jr., K.P. LeClair, H. Singh, and P.A. Sharp. 1990. A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes. Mol. Cell. Biol. 10:1406-1414.
23. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 9:2736-2746.
24. van Kooten, C., and J. Banchereau. 1997. Functional role of CD40 and its ligand. Int. Arch. Allergy Immunol. 113:393-399.
25. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267:1449-1456.
26. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
27. Frevert, C.W., S. Huang, H. Danaee, J.D. Paulauskis, and L. Kobzik. 1995. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J. Immunol. 154:335-344.
28. Driscoll, K.E., D.G. Hassenbein, B.W. Howard, R.J. Isfort, D. Cody, M.H. Tindal, M. Suchanek, and J.M. Carter. 1995. Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J. Leukocyte Biol. 58:359-364.
29. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EBMBO (Eur. Mol. Biol. Organ.) J. 15:7099-7107.
30. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature. 364:806-809.
31. Behrmann, I., H. Walczak, and P.H. Krammer. 1994. Structure of the human APO-1 gene. Eur. J. Immunol. 24:3057-3062.
32. Wang, C.Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:784-787.
33. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:787-789.
34. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:565-576.
35. Kang, S.M., D.B. Schneider, Z. Lin, D. Hanahan, D.A. Dichek, P.G. Stock, and S. Baekkeskov. 1997. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738-743.
36. Chervonsky, A.V., Y. Wang, F.S. Wong, I. Visintin, R.A. Flavell, C.A. Janeway, Jr., and L.A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell. 89:17-24.
37. Waldner, H., R.A. Sobel, E. Howard, and V.K. Kuchroo. 1997. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:3100-3103.
38. Benoist, C., and D. Mathis. 1997. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell. 89:1-3.